542 related articles for article (PubMed ID: 10694319)
1. The use of systemic antimycotics in dermatotherapy.
Niewerth M; Korting HC
Eur J Dermatol; 2000 Mar; 10(2):155-60. PubMed ID: 10694319
[TBL] [Abstract][Full Text] [Related]
2. The systemic treatment of onychomycosis.
Wenig JA
Clin Podiatr Med Surg; 1995 Apr; 12(2):263-74. PubMed ID: 7600500
[TBL] [Abstract][Full Text] [Related]
3. The use of oral antifungal agents to treat onychomycosis.
Gupta AK; Ryder JE
Dermatol Clin; 2003 Jul; 21(3):469-79, vi. PubMed ID: 12956199
[TBL] [Abstract][Full Text] [Related]
4. [Modern antimycotics. What the treating physician needs to know].
Seebacher C
Hautarzt; 2004 Feb; 55(2):150-6. PubMed ID: 14968325
[TBL] [Abstract][Full Text] [Related]
5. Toenail onychomycosis: current and future treatment options.
Finch JJ; Warshaw EM
Dermatol Ther; 2007; 20(1):31-46. PubMed ID: 17403258
[TBL] [Abstract][Full Text] [Related]
6. New antifungal therapy for children.
Suarez S
Adv Dermatol; 1997; 12():195-208; discussion 209. PubMed ID: 8973741
[No Abstract] [Full Text] [Related]
7. The significance of itraconazole for treatment of fungal infections of skin, nails and mucous membranes.
Korting HC; Schöllmann C
J Dtsch Dermatol Ges; 2009 Jan; 7(1):11-9, 11-20. PubMed ID: 18479501
[TBL] [Abstract][Full Text] [Related]
8. The new oral antifungal agents for onychomycosis of the toenails.
Gupta AK; Shear NH
J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624
[TBL] [Abstract][Full Text] [Related]
9. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
[TBL] [Abstract][Full Text] [Related]
10. Dermatophytosis: the management of fungal infections.
Gupta AK; Ryder JE; Chow M; Cooper EA
Skinmed; 2005; 4(5):305-10. PubMed ID: 16282753
[TBL] [Abstract][Full Text] [Related]
11. Current trends in onychomycosis therapy: a literature review.
Hecker D
Mt Sinai J Med; 1997 Nov; 64(6):399-405. PubMed ID: 9364835
[TBL] [Abstract][Full Text] [Related]
12. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
[TBL] [Abstract][Full Text] [Related]
13. Oral therapy for onychomycosis: an evidence-based review.
de Sá DC; Lamas AP; Tosti A
Am J Clin Dermatol; 2014 Feb; 15(1):17-36. PubMed ID: 24352873
[TBL] [Abstract][Full Text] [Related]
14. The systemic treatment of onychomycosis.
Wenig JA
Clin Podiatr Med Surg; 2004 Oct; 21(4):579-89, vi. PubMed ID: 15450898
[TBL] [Abstract][Full Text] [Related]
15. Current concepts in systemic and topical therapy for superficial mycoses.
Millikan LE
Clin Dermatol; 2010 Mar; 28(2):212-6. PubMed ID: 20347665
[TBL] [Abstract][Full Text] [Related]
16. The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis.
Chang CH; Young-Xu Y; Kurth T; Orav JE; Chan AK
Am J Med; 2007 Sep; 120(9):791-8. PubMed ID: 17765049
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents.
Gupta AK; Del Rosso JQ
Int J Dermatol; 2000 Jun; 39(6):401-11. PubMed ID: 10944084
[No Abstract] [Full Text] [Related]
18. Terbinafine. An update of its use in superficial mycoses.
McClellan KJ; Wiseman LR; Markham A
Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
[TBL] [Abstract][Full Text] [Related]
19. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
Angello JT; Voytovich RM; Jan SA
Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095
[TBL] [Abstract][Full Text] [Related]
20. Fungal nail infections: diagnosis and management.
Prescrire Int; 2009 Feb; 18(99):26-30. PubMed ID: 19391293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
